VEROTOXIN-RESISTANT CELL CLONES ARE DEFICIENT IN THE GLYCOLIPID GLOBOTRIOSYLCERAMIDE - DIFFERENTIAL BASIS OF PHENOTYPE

被引:39
作者
PUDYMAITIS, A
ARMSTRONG, G
LINGWOOD, CA
机构
[1] HOSP SICK CHILDREN,RES INST,DIV MICROBIOL,TORONTO M5G 1X8,ONTARIO,CANADA
[2] UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA
[3] UNIV ALBERTA,DEPT MED MICROBIOL & INFECT DIS,EDMONTON T6G 2E1,ALBERTA,CANADA
[4] HOSP SICK CHILDREN,RES INST,DIV BIOCHEM,TORONTO M5G 1X8,ONTARIO,CANADA
[5] UNIV TORONTO,DEPT BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA
[6] UNIV TORONTO,DEPT MICROBIOL,TORONTO M5S 1A1,ONTARIO,CANADA
关键词
D O I
10.1016/0003-9861(91)90064-P
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Escherichia coli-derived verotoxin is an extremely toxic protein and is highly selective toward certain primate cells. Two susceptible cell lines are the Daudi cell line (human Burkitt lymphoma) and the Vero cell line (Green African monkey kidney). Both of these cell lines contain significant levels of the verotoxin binding glycolipid globotriosylceramide (Gb3) (1 nmol/107 cells and 3 nmol/106 cells, respectively). A clone was selected from the Vero cell line for resistance to Verotoxin 2, while a mutant from the Daudi cell line was selected for resistance to Verotoxin 1. Both were found to be deficient in globotriosylceramide with a corresponding increase in the precursor glycolipid lactosylceramide. Cell free assay of α-galactosyltransferase activity revealed that the Vero cell clone (VRP) contained significantly reduced enzyme activity, whereas in the case of the Daudi mutant (VT20), no significant decrease in activity was noted in vitro. These observations suggest a complex regulation of Gb3 biosynthesis which is considered in relation to P blood group antigen expression. © 1991.
引用
收藏
页码:448 / 452
页数:5
相关论文
共 24 条
[1]   IDENTIFICATION OF UDP-GALACTOSE - LACTOSE (LACTOSYLCERAMIDE) ALPHA-4 AND BETA-3 GALACTOSYLTRANSFERASES IN HUMAN-KIDNEY [J].
BAILLY, P ;
PILLER, F ;
CARTRON, JP ;
LEROY, Y ;
FOURNET, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (01) :84-91
[2]  
BASU M, 1987, METHOD ENZYMOL, V138, P575
[3]  
CHATTERJEE S, 1988, J BIOL CHEM, V263, P13017
[4]  
COHEN A, 1987, J BIOL CHEM, V262, P17088
[5]   EXPRESSION OF GLYCOLIPID RECEPTORS TO SHIGA-LIKE TOXIN ON HUMAN LYMPHOCYTE-B - A MECHANISM FOR THE FAILURE OF LONG-LIVED ANTIBODY-RESPONSE TO DYSENTERIC DISEASE [J].
COHEN, A ;
MADRIDMARINA, V ;
ESTROV, Z ;
FREEDMAN, MH ;
LINGWOOD, CA ;
DOSCH, HM .
INTERNATIONAL IMMUNOLOGY, 1990, 2 (01) :1-8
[6]  
DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520
[7]   INTERACTION OF SHIGELLA SHIGAE CYTO-TOXIN WITH RECEPTORS ON SENSITIVE AND INSENSITIVE CELLS [J].
EIKLID, K ;
OLSNES, S .
JOURNAL OF RECEPTOR RESEARCH, 1980, 1 (02) :199-213
[8]  
FOLCH J, 1957, J BIOL CHEM, V226, P497
[9]  
FYFE G, 1987, J IMMUNOL, V139, P2187
[10]   PURIFICATION AND CHARACTERIZATION OF VEROCYTOTOXIN-2 [J].
HEAD, SC ;
PETRIC, M ;
RICHARDSON, S ;
ROSCOE, M ;
KARMALI, MA .
FEMS MICROBIOLOGY LETTERS, 1988, 51 (2-3) :211-215